are glp 1 patches good Do Work? Evidence, Safety, & What Actually Helps Do GLP-1 Patches Really Work?

Durand RE, Olive PL

Novo Nordisk - Regulatory Approval (December 2025): FDA approved the first oral GLP-1 for weight loss-Novo Nordisk's once-daily semaglutide pill-which launched in January 2026 [3]

Its multifaceted approach to muscle health sets it apart

Long-term safety considerations Available safety data: 40+ years of Russian research and use Thousands of patients in clinical studies Extensive animal safety testing No serious adverse events reported in research Generally recognized as safe in research context Lack of Western data: No large-scale FDA clinical trials Limited peer-reviewed English publications Most data from Russian institutes Skepticism about research quality standards Need international replication Theoretical long-term concerns: Monitoring recommendations: Annual comprehensive physical exam Blood work: CBC, CMP, lipids, inflammatory markers Cancer screening per age-appropriate guidelines Sleep tracking (subjective and objective) Document any changes or concerns Work with peptide-knowledgeable physician Conservative approach: Start with proven 10-day cycles Monitor response carefully Don't exceed recommended dosing Combine with healthy lifestyle View as one tool in longevity strategy Learn about peptide safety at SeekPeptides

Taken together, these findings suggest GLP-1 RAs could broaden the therapeutic toolkit for HS, particularly for patients with concomitant obesity, and potentially even for those without, via anti-inflammatory effects

J Diabetes Res (2019) 2019:9426014